2026 SBMA Research Grants
The 2026 SBMA Research Grants from the Kennedy's Disease Association fund innovative research to advance understanding and treatment of Kennedy's Disease (SBMA) through basic, translational, or clinical science.
Funder: Kennedy's Disease Association
Due Dates (Anticipated): June 2027 (Full proposal submission)
Funding Amounts: Up to $100,000 for one year or $50,000/year for two years; indirect costs capped at 5%
Summary: Supports research advancing the understanding and treatment of Kennedy's Disease (SBMA), fostering both basic and translational science.
Key Information: Forecasted opportunity; all dates are projected—confirm details on the program site.
Description
The Kennedy's Disease Association (KDA) offers research grants to promote innovative scientific studies on the mechanisms and treatment of Kennedy's Disease (Spinal and Bulbar Muscular Atrophy, SBMA). The program aims to foster high-quality research that may lead to breakthroughs in disease management, therapy development, or a cure. Both junior investigators and experienced researchers are encouraged to apply, with projects spanning basic, translational, or clinical research relevant to SBMA. The KDA emphasizes dissemination of results and community impact, including presentations at the annual KDA Conference and publication of findings.
